A new method for the construction of 3-aminoindole nucleosides of 2-acetamido-2-deoxy-D-glucose based is presented. Nitration and acetylation of the indole nucleosides by acetic anhydride-nitric acid mixture followed by reduction using silver catalyst (SNSM) impregnated on silica gel, afforded the corresponding amino indole nucleosides. The nucleosides were tested for antiviral activity against hepatitis B virus (HBV) to show different degrees of antiviral activities or inhibitory actions.
Introduction
Metallic nanoparticles, especially silver nanoparticles, have attracted much attention because they have already shown promises in catalysis [1] [2] [3] [4] and SERS (surface enhanced Raman scattering) studies.
5
Indoles are important in both the biological and material sciences. 6 Among the wide variety of privileged indole scaffold structures, the novel 3-aminoindole core appeared only recently. 3-Aminoindole derivatives, though not easily accessible, have nevertheless emerged as promising agents with potential application against a large number of diseases.
7-13 3-Aminoindole-based compounds are commonly prepared from the corresponding 3-substituted indoles 7, 8, [14] [15] [16] [17] indoxyls, 9, 18 and non-indolic precursors. [10] [11] [12] 19, 20 As a part of the program aimed at the development of new nucleoside derivatives with potential biological activities, 21 we describes herein the new method for the construction of 3-aminoindole nucleosides of 2-acetamido-2-deoxy-D-glucose and its antiviral activity against hepatitis B virus (HBV).
Experimental Section
Melting points were determined using a Büchi apparatus. All solvents were purified according to the standard procedures. TLC was performed on plastic plates Silica Gel 60 F 245 (E. Merck, layer thickness 0.2 mm). The detection was achieved by treatment with a solution of 15% H 2 SO 4 in methanol, and heating at 150 o C.
1
H-NMR spectra were recorded with a Varian Gemini spectrometer at 300 MHz with TMS as a standard. Chemical shifts were reported in δ scale (ppm) relative to TMS as a standard, and the coupling constants (J values) are given in Hz. EI-mass spectra were recorded with a HP D5988 A 1000 MHz instrument (Hewlett-Packard, Palo Alto, CA, USA). Elemental analyses (C, H and N) were carried out at the Microanalytical Center of Cairo University, Giza, Egypt. The elemental analyses were found to agree favorably with the calculated values. Silver Nanoparticles were prepared according to the published procedures.
5,22-24 2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-glucopyranosyl chloride (2) was prepared according to the published procedure. 1-(2'-Acetamido-3',4',6'-tri-O-acetyl-2'-deoxy-β-D-glucopyranosyl)-3-nitroindoles (4a-c). Acetyl nitrate was generated by the dropwise addition of neat yellow 90% HNO 3 (1.35 mL, 30 mmol) to Ac 2 O (20 mL) which cooled at (0 o C) followed by standing at room temperature for 10 min and was used immediately. To a stirred solution of 3a-c (1 mmol) in Ac 2 O (2 mL) cooled at -70 o C was added a solution of the acetyl nitrate dropwise via addition funnel over 30 min. The mixture was then allowed to warm to room temperature with stirring overnight. The reaction mixture was poured on crushed ice and then extracted with CH 2 C1 2 (100 mL). The solvent was dried over Na 2 SO 4 , evaporated, and coevaporated with toluene to afford a yellow solid which was purified by recrystallization using absolute ethanol to afford 4a-c.
1 Procedure for the Reduction of Nitro-Compounds using Solid Silver as Catalyst, SNSM to Afford 1-(2'-Acetamido-β-D-glucopyranosyl)-3-aminoindoles (5a-c).
Step (i): Compounds 4a-c (0.5 mmol) in a stirred mixture of methanol (5 mL) and ammonium hydroxide (25%) (5 mL) were stirred at room temperature for 2 h. The resulting solution was evaporated till dryness under reduced pressure.
Step (ii): In a standard quartz cuvette having a 1-cm path length, 2 mL of water and 20 μL of nitrocompounds (resulting from step i) (final concentration in solution: 4.3 × 10 −4 M) were taken. To it was added 300 μL of aqueous NaBH 4 (0.1 M). It took 5 min for the peak of the colorless product to appear (induction time, IT) in the blue region after the addition of (0.0053 g) solid silica gel impregnated silver catalyst, SNSM.
6 Then the gradual decoloration of the yellow solution (due to nitrocompounds) and the formation of the product were observed through UV-visible spectrophotometry ( Fig. 1) . After the yellow color was completely discharged, i.e., the completed reaction was, the peak due to nitrocompounds was no longer observed. On the other hand, the appearance of a new peak at 430 nm was noticed 5 min after of the completion of the reaction. The solvent was evaporated under reduced pressure and the residue was dissolved in absolute ethanol and left at room temperature for overnight to afford 5a-c as a pale yellow crystals. 1-(2'-Acetamido-β-D-glucopyranosyl)-3-nitro-6-substitutes amino-indoles (6) (7) (8) (9) (10) (11) . A solution of 4b (0.570 g, 1 mmoL) and an excess of the appropriate amine was stirred under reflux for 2 h. The solvent was removed in vacuo and the residue was recrystallized from ethanol to give 6-11.
1-(2'-Acetamido-β-D-glucopyranosyl)-6-methylamino-3-nitroindole (6) 3 H, NHCOCH 3 ), 3.28-3.45 (m, 6 H, H-6', 2 x NCH 2 ),  3.55-3.75 (m, 2 H, H-4', H-5'), 3.83 (m, 1 H, H-3'), 4.21 (m,  1 H, H-2'), 5.33-5.44 (m, 3 H, 3 OH), 5.65 (s, 1 H, H-1'),  6.15-6.37 (m, 4H, H-5, H-7, NH 2 ), 7.05-7.15 (m, 1 H, H-2 
Antiviral Testing
The HepG2.2.2.15 cell line, supplied by State Serum Institute, Denmark, was maintained in RPMI-1640 Glutamax, Gibco BRL Life technologies. 26, 27 The standard drug Lamivudine was from GlaxoSmithKline. The cell line was maintained in RPMI-1640 (Glutamax) culture medium containing 100 IU/mL nystatin, 380 µg/mL G418 (genetecin) and 10% fetal calf serum (FCS) (Gibco BRL Life Technologies). The transferred HEPG2.2.2.15 cells were kept in a tissue culture flask at 37 o C and 5% CO 2 . Subcultures were set up after a week by trypsination (10% versin/trypsin (Biochrome KG) and transferred to a 96-well tissue culture plate. 5-Fold serial dilutions of tested compounds with final concentrations ranging from 100 to 0.03 µM were added to the cell suspension and incubated for 6 d at 37 o C and 5% CO 2 . Each compound was tested in triplicate. Cells with no compounds added to their culture were used for comprison (blank cells).
DNA Extraction. DNA extraction was done by incubating 10 µL of diluted supernatant with 10 µL of 0.2 M NaOH at 37 ºC for 1 h, then carefully adding 9.6 µL of 0.2M HCl followed by addition of 90 µL of Tris-EDTA buffer [(2-amino-2-(hydroxymethyl)-1,3-propanediol-EDTA) (Gibco BRL Life Technologies)].
PCR-ELISA Detection of HBV DNA. The DNA content in the cell culture supernatant was determined by polymerase chain reaction amplification of the HBV DNA using 1 µmol/L of each of the following primers: HCID-1 primer (5'-GGAAAGAAGTCAGAAGGCA-3') and HCID-2 primer (5'-TTGGGGGAGGAGATTAGGTT-3'), in a reaction mixture containing 14 µL extracted supernatant, 4 mmol/L MgCl 2 , 10 µmol/L DIG-11-dUTP (Roche, Germany), 190 µmol/L dTTP, 200 µmol/L dATP, dGTP, dCTP (Roche) 1.5 U Taq polymerase (Roche), in a total volume 50 µL. PCR reaction conditions were: 32 cycles of 10 min at 94 ºC, 30 s at 58 ºC, and 30 s at 72 ºC with a 3 s increment for each cycle in a Perkin Elmer 480 thermal cycler (Perkin Elmer, USA). The PCR product was detected by DIG-ELISA assay (Roche). The optical density from DNA of the test compound was compared to that of the blank culture.
28,29
Cytotoxicity Assay. 3-(3,5-Dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (Sigma, USA) is a colorless substrate that is transformed to a colored product by living cells, but not by dead cells. The assay utilizes this compound to test for the viability of the cells with the test compound added compared to the viability of the blank cells.
30

Results and Discussion
The ease of accessibility and the biological significance of 2-acetamido-2-deoxy-D-glucose [31] [32] [33] have prompted us to use this aminosugar as a starting material in Sasaki glycosylation reaction. 34 Thus, the sodium salt of indole derivatives 1a-c was condensed with 2-acetamido-1-chloro-3,4,6-tri-Oacetyl-2-deoxy-D-glucose (2) 25 in dry DMF. The reaction was proceeded at 90 o C to give the desired 1-(2'-acetamido-3',4',6'-tri-O-acetyl-2'-deoxy-β-D-glucopyranosyl)indoles (3a-c) (Scheme 1).
The structure of the nucleosides 3a-c was determined on the basis of its respective 1 H-NMR, mass spectra and microanalyses, which was found to be consistent with the assigned structure by comparison with the structures of glycopyranoside analogues. [35] [36] [37] The 1 H-NMR spectrum of 3a-c showed the anomeric proton peaks at δ 5.59-5.66 ppm as a doublet with J 1',2' coupling constant of 9.4 Hz. Coupling constant of 9.4 Hz in sugar moieties normally results from the diaxial orientation of H-1' and H-2' protons, which is clearly indicative of the β-configuration of the products. [35] [36] [37] The methyl protons of the acetamido group (NHCOCH 3 ) appeared as singlet at δ 1.75-1.77 ppm, while the other three acetyl groups appeared as singlet at δ 1.99-2.12, respectively.
Nitration of 3a-c using acetic anhydride-nitric acid mixture afforded the corresponding 3-nitroindole nucleoside derivatives 4a-c. The ature resulted in the aminolysis of three acetyl groups and the nitro group of the crude intermediates were reduced directly by solid silica gel impregnated silver catalyst (SNSM) to afford the corresponding amino indole nucleosides 5a-c.
Treatement of 4b with different primary and secondary amines at reflux temperature afforded the corresponding 3-nitro-6-substituted aminoindoles 6-11, respectively. Reduction of the 3-nitro group again by solid silica gel impregnated silver catalyst (SNSM) provided the new amino indole nucleosides 12-17.
The compounds were tested for their antiviral activity and cytotoxicity against HBV using the HepG2.2.2.15 cell line, a human hepatoma cell line producing HBV viral particles.
26,27
The drug Lamivudine (4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one), a potent selective inhibitor of HBV replication, 28 has been used as a standard positive control. The 50% inhibitory concentration (IC 50 ) of an antiviral drug was determined by plotting the DNA content in the cell culture supernatant versus the concentration of the test compound. The 50% cytotoxic effect (CC 50 ) was calculated from the average viability of the cells in proportion to the concentration of the drug; for all the tested compounds its value was 100 μM. The selectivity index (SI) was calculated as CC 50 /IC 50 . 29, 30 The results of the antiviral activity measurements against HBV are shown in the Table 1 . Preliminary screening indicated that compound 6 and 16 showed the highest inhibitory activity against HBV among this series of tested compounds with low cytotoxicity and a selectivity index of 2500.0 followed by compounds 3c, 5a, 5c and 17. Compounds 4a-c, 5b, 8, 10, 11 and 14 showed moderate inhibition with moderate cytotoxicity while the other tested compounds exhibited less activity against HBV.
Conclusions
In conclusion, a new and versatile approach to the synthesis of 3-aminoindole nucleosides of 2-acetamido-2-deoxy-D-glucose was established. The use of modified heterocyclic base in nucleoside synthesis as well as the convenient experimental conditions merits the efficiency of this approach. Cytotoxic effect (CC50) of all tested compounds is 100 µM.
